drugset / Trial / NCT03698513
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will investigate the safety and interaction of BMS-986177 in healthy volunteers, when administered with Aspirin and/or Clopidogrel
Timeline
- Start
- 2018-10-04
- Primary completion
- 2019-02-19
- Completion
- 2019-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | — |
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Milvexian | Small molecule | 200 mg | Oral |
Indications
No indication recorded.